Case Study: Highlands Oncology increases clinical trial participation by 45% with Paradigm Health

Highlands Oncology Increased Clinical Trial Participation by 45%

Highlands Oncology, a leading community-based cancer center, sought to reduce the administrative burden on its research team and scale its patient recruitment operations for over 100 clinical trials. The manual process of evaluating trial opportunities and screening patients was time-consuming and inefficient. They partnered with vendor Paradigm Health to implement its Platform and clinical services to address these challenges.

Paradigm Health integrated its Platform with Highlands' EMR and molecular testing data, using machine learning to enrich patient records and automate the matching of eligible patients to trials. This solution streamlined feasibility analyses and patient screening. As a result, Paradigm Health helped Highlands Oncology increase clinical trial patient enrollment by 45% over two years while simultaneously reducing the burden on its research department.

Highlands Oncology

Adam Torres

Director of Research Development